ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) Short Interest Down 18.7% in March

ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) was the recipient of a significant decline in short interest in March. As of March 31st, there was short interest totaling 4,071 shares, a decline of 18.7% from the March 15th total of 5,007 shares. Currently, 0.2% of the company’s stock are short sold. Based on an average trading volume of 31,640 shares, the days-to-cover ratio is currently 0.1 days.

Institutional Investors Weigh In On ALPS Medical Breakthroughs ETF

Several hedge funds and other institutional investors have recently modified their holdings of the company. Delta Investment Management LLC bought a new stake in shares of ALPS Medical Breakthroughs ETF during the fourth quarter valued at approximately $6,112,000. LPL Financial LLC increased its holdings in shares of ALPS Medical Breakthroughs ETF by 438.7% during the fourth quarter. LPL Financial LLC now owns 42,755 shares of the company’s stock valued at $2,190,000 after acquiring an additional 34,819 shares in the last quarter. Griffin Asset Management Inc. increased its holdings in shares of ALPS Medical Breakthroughs ETF by 1.9% during the fourth quarter. Griffin Asset Management Inc. now owns 30,699 shares of the company’s stock valued at $1,572,000 after acquiring an additional 564 shares in the last quarter. Jones Financial Companies Lllp bought a new stake in shares of ALPS Medical Breakthroughs ETF during the first quarter valued at approximately $782,000. Finally, Moran Wealth Management LLC increased its holdings in shares of ALPS Medical Breakthroughs ETF by 22.7% during the fourth quarter. Moran Wealth Management LLC now owns 21,084 shares of the company’s stock valued at $1,080,000 after acquiring an additional 3,897 shares in the last quarter.

ALPS Medical Breakthroughs ETF Trading Up 2.0%

Shares of NYSEARCA SBIO traded up $1.15 during midday trading on Friday, hitting $57.52. 19,853 shares of the stock traded hands, compared to its average volume of 35,650. ALPS Medical Breakthroughs ETF has a one year low of $26.28 and a one year high of $57.77. The business has a 50 day moving average price of $51.42 and a two-hundred day moving average price of $48.95.

ALPS Medical Breakthroughs ETF Company Profile

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.